Derek T. Chalmers, President & CEO at Cara Therapeutics, Inc. (CARA), sold 31,398 shares at $25.79 ($623K) on 2019-12-02, disclosed to the SEC on 2019-12-04.
Open-market sale of $623k CARA by President & CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $25.79 | 10,000 | $258K | 41.4% |
| 2 | $17.05 | 10,699 | $182K | 29.3% |
| 3 | $17.05 | 10,699 | $182K | 29.3% |
| Total | $19.83 avg | 31,398 | $623K | 100% |
| Filing → |
| CARA | SELL | 2021-03-08 | $112K | — | Filing → |
| CARA | SELL | 2021-02-25 | $453K | — | Filing → |
| CARA | SELL | 2020-12-30 | $186K | — | Filing → |